Lupin gets red flag from USFDA for significant violations in manufacturing practice

05 Oct 2019 Evaluate

US Food and Drug Administration (USFDA) has red flagged Lupin for significant violations of the current good manufacturing practice regulations at its Mandideep facility in Madhya Pradesh. The violations pointed out in a warning letter by the USFDA include inadequacy of the cleaning process for manufacturing equipment.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.


Lupin Share Price

2176.25 -18.75 (-0.85%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×